ConductScience.org, home

Paper484687

Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma.

Keates EU. Am J Ophthalmol, 1979. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma. Papers, record 484687. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/484687

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evaluation of timolol maleate combination therapy in chronic open-angle glaucoma.
PubMed
Journal
Am J Ophthalmol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
3.63
iCite
Revised in PubMed
2019-06-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Keates EUE U

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlaucomaMajor topic
PropanolaminesMajor topic
TimololMajor topic
Acetazolamide
Adult
Aged
Carbachol
Drug Therapy, Combination
Epinephrine
Female
Humans
Intraocular Pressure
Male
Middle Aged
Pilocarpine

Source PubMed

Download CSV of topics

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
19668385Managing refractory glaucoma with a fixed combination of bimatoprost (0.03%) and timolol (0.5%).Clin Ophthalmol2008https://conductscience.org/library/papers/19668385PubMed
10776828Pharmacological therapy for glaucoma: a review.Drugs2000https://conductscience.org/library/papers/10776828PubMed
7039666Dose response of oral timolol combined with adrenaline.Br J Ophthalmol1982https://conductscience.org/library/papers/7039666PubMed
7004479Interaction of timolol and adrenaline.Br J Ophthalmol1981https://conductscience.org/library/papers/7004479PubMed
7000172Addition of timolol maleate to routine medical therapy: a clinical trial.Br J Ophthalmol1980https://conductscience.org/library/papers/7000172PubMed
6906160[The effect of timolol and dipivalyl-epinephrine in the treatment of the elevated intraocular pressure (author's transl)].Albrecht Von Graefes Arch Klin Exp Ophthalmol1980https://conductscience.org/library/papers/6906160PubMed
6838801Ocular sympathetic denervation associated with ocular hypertension: a case report.Br J Ophthalmol1983https://conductscience.org/library/papers/6838801PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/484687

GET https://conductscience.org/api/papers/v1/484687/authors